Skip to main content

Table 3 Serum 25(OH)VD levels in CHC patients at baseline and after DAA curative treatment comparing cirrhotic and non-cirrhotic patients

From: Changes in hepatic fibrosis and vitamin D levels after viral hepatitis C eradication using direct-acting antiviral therapy

  Week 0 (ng/mL) Week 24 (ng/mL) Week 48a (ng/mL)
Cirrhotic (n = 63) 25.0 ± 10.5 20.2 ± 8.1 19.9 ± 8.2
Non-cirrhotic (n = 17) 31.0 ± 10.3 22.8 ± 7.7 24.1 ± 9.4
p value 0.039 0.251 0.087
  1. aSix patients were lost to follow-up at 48 weeks; 5 in cirrhotic group and 1 in non-cirrhotic group